Real-World Tocilizumab Use in Patients With Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study

Rheumatology and Therapy
doi 10.1007/s40744-018-0130-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Incidence of Gastrointestinal Perforations in Patients With Rheumatoid Arthritis Treated With Tocilizumab From Clinical Trial, Postmarketing, and Real-World Data Sources

Rheumatology and Therapy
2016English

Real-World Outcomes in Fingolimod-Treated Patients With Multiple Sclerosis in the Czech Republic: Results From the 12-Month GOLEMS Study

Clinical Drug Investigation
MedicinePharmacology
2016English

Biologic Monotherapy in the Biologic Naïve Patient With Rheumatoid Arthritis (RA): Results From an Observational Study

Rheumatology International
RheumatologyAllergyImmunology
2020English

Outcomes of Disease Activity in Rheumatoid Arthritis and Health Insurance: Results From Real World

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Treatment of Patients With Rheumatoid Arthritis: Real World Population-Based Evidence From France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

FRI0248 Incidence of Melanoma in Patients With Rheumatoid Arthritis Treated With Tocilizumab

2017English

Results of the Long-Term Observational Noninterventional Prospective Study BODYGUARD in Psoriasis Patients

Vestnik dermatologii i venerologii
2019English

Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis

Archives of Rheumatology
Rheumatology
2019English

Longitudinal Immunomonitoring Following Tocilizumab in Rheumatoid Arthritis

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy